Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Oct;10(10):654-5.
doi: 10.1016/S1473-3099(10)70192-4. Epub 2010 Sep 9.

Maximising the public health benefit of antimalarials

Ric N Price, Nicholas M Douglas
Comment

Maximising the public health benefit of antimalarials

Ric N Price et al. Lancet Infect Dis. 2010 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Smithuis F, Kyaw MK, Phe O, et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis. 2010 published online Sept 9. DOI:10.1016/S1473-3099(10)70187-0. - PMC - PubMed
    1. Ratcliff A, Siswantoro H, Kenangalem E, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet. 2007;369:757–65. - PMC - PubMed
    1. Hastings IM, Watkins WM. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol. 2006;22:71–77. - PubMed
    1. Stepniewska K, Price RN, Sutherland CJ, et al. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J. 2008;7:249. - PMC - PubMed
    1. Smithuis F, Kyaw MK, Phe O, et al. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet. 2006;367:2075–85. - PubMed

MeSH terms